![](/images/general/no_picture/200_user.png)
Matthew J Peerce
Examiner (ID: 3603, Phone: (571)272-6570 , Office: P/2875 )
Most Active Art Unit | 2875 |
Art Unit(s) | 2875 |
Total Applications | 592 |
Issued Applications | 390 |
Pending Applications | 57 |
Abandoned Applications | 144 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8523604
[patent_doc_number] => 20120323012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => '4-(AZACYCLOALKYL) -BENZENE-1,3-DIOL DERIVATIVES AS TYROSINASE INHIBITORS AND THEIR SYNTHESIS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/514282
[patent_app_country] => US
[patent_app_date] => 2010-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4464
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/514282 | 4-(AZACYCLOALKYL) -BENZENE-1,3-DIOL DERIVATIVES AS TYROSINASE INHIBITORS AND THEIR SYNTHESIS AND USE THEREOF | Dec 7, 2010 | Abandoned |
Array
(
[id] => 8063613
[patent_doc_number] => 20110245223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'HETEROCYCLIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/958071
[patent_app_country] => US
[patent_app_date] => 2010-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94463
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245223.pdf
[firstpage_image] =>[orig_patent_app_number] => 12958071
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/958071 | HETEROCYCLIC COMPOUNDS | Nov 30, 2010 | Abandoned |
Array
(
[id] => 5978178
[patent_doc_number] => 20110071190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/956143
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24758
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071190.pdf
[firstpage_image] =>[orig_patent_app_number] => 12956143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/956143 | Biphenyl compounds useful as muscarinic receptor antagonists | Nov 29, 2010 | Issued |
Array
(
[id] => 9552329
[patent_doc_number] => 08759377
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction'
[patent_app_type] => utility
[patent_app_number] => 12/952640
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37027
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952640
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/952640 | Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | Nov 22, 2010 | Issued |
Array
(
[id] => 8211286
[patent_doc_number] => 20120129827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'NOVEL DERIVATIVES OF 1-ALKYL-6-OXO-PIPERIDINE-3-CARBOXYLIC ACIDS AND 1-ALKYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACIDS AND THEIR USES AS COOLING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/951173
[patent_app_country] => US
[patent_app_date] => 2010-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5406
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129827.pdf
[firstpage_image] =>[orig_patent_app_number] => 12951173
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/951173 | Derivatives of 1-alkyl-6-oxo-piperidine-3-carboxylic acids and 1-alkyl-5-oxo-pyrrolidine-3-carboxylic acids and their uses as cooling compounds | Nov 21, 2010 | Issued |
Array
(
[id] => 9060138
[patent_doc_number] => 08546573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate'
[patent_app_type] => utility
[patent_app_number] => 12/943601
[patent_app_country] => US
[patent_app_date] => 2010-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5508
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12943601
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/943601 | Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate | Nov 9, 2010 | Issued |
Array
(
[id] => 9227557
[patent_doc_number] => 08633225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Piperidinium compounds and cosmetic compositions containing them'
[patent_app_type] => utility
[patent_app_number] => 12/940284
[patent_app_country] => US
[patent_app_date] => 2010-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12455
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12940284
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/940284 | Piperidinium compounds and cosmetic compositions containing them | Nov 4, 2010 | Issued |
Array
(
[id] => 8336305
[patent_doc_number] => 20120203005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'POLYMORPH OF 3-(SUBSTITUTEDDIHYDROISOINDOLINONE-2-YL)-2,6-DIOXOPIPERIDINE, AND PHARMACEUTICAL COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/501437
[patent_app_country] => US
[patent_app_date] => 2010-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 12822
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501437
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/501437 | Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof | Nov 1, 2010 | Issued |
Array
(
[id] => 6144823
[patent_doc_number] => 20110130424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'SUBSTITUTED PHENYLPIPERIDINES WITH SEROTONINERGIC ACTIVITY AND ENHANCED THERAPEUTIC PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 12/916894
[patent_app_country] => US
[patent_app_date] => 2010-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27341
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130424.pdf
[firstpage_image] =>[orig_patent_app_number] => 12916894
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/916894 | SUBSTITUTED PHENYLPIPERIDINES WITH SEROTONINERGIC ACTIVITY AND ENHANCED THERAPEUTIC PROPERTIES | Oct 31, 2010 | Abandoned |
Array
(
[id] => 10070596
[patent_doc_number] => 09108939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => '(1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 13/504209
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29044
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504209 | (1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis | Oct 25, 2010 | Issued |
Array
(
[id] => 8348092
[patent_doc_number] => 20120209005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'FUSED HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS'
[patent_app_type] => utility
[patent_app_number] => 13/503560
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31872
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503560 | Fused heterocyclic compounds and thrombopoietin receptor activators | Oct 21, 2010 | Issued |
Array
(
[id] => 7501628
[patent_doc_number] => 20110263556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'New Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/908172
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37664
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12908172
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/908172 | Compounds | Oct 19, 2010 | Issued |
Array
(
[id] => 9020678
[patent_doc_number] => 08530664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Catalysts for the preparation of methylpyridine'
[patent_app_type] => utility
[patent_app_number] => 12/903550
[patent_app_country] => US
[patent_app_date] => 2010-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3844
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12903550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/903550 | Catalysts for the preparation of methylpyridine | Oct 12, 2010 | Issued |
Array
(
[id] => 8336098
[patent_doc_number] => 20120202802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'SPIROCYCLIC COMPOUNDS AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/500323
[patent_app_country] => US
[patent_app_date] => 2010-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24912
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500323
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500323 | Spirocyclic compounds as modulators of chemokine receptor activity | Oct 5, 2010 | Issued |
Array
(
[id] => 6033188
[patent_doc_number] => 20110082113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/896955
[patent_app_country] => US
[patent_app_date] => 2010-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15629
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082113.pdf
[firstpage_image] =>[orig_patent_app_number] => 12896955
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896955 | Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity | Oct 3, 2010 | Issued |
Array
(
[id] => 5993903
[patent_doc_number] => 20110015400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'PROCESS FOR THE PREPARATION OF TRYPTASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/895068
[patent_app_country] => US
[patent_app_date] => 2010-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17732
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015400.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895068
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895068 | PROCESS FOR THE PREPARATION OF TRYPTASE INHIBITORS | Sep 29, 2010 | Abandoned |
Array
(
[id] => 5954367
[patent_doc_number] => 20110034511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'SUBSTITUTED 2-CARBONYLAMINO-6-PIPERIDINAMINOPYRIDINES AND SUBSTITUTED 1-CARBONYLAMINO-3-PIPERIDINAMINOBENZENES AS 5-HT1F AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/892433
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38687
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12892433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/892433 | SUBSTITUTED 2-CARBONYLAMINO-6-PIPERIDINAMINOPYRIDINES AND SUBSTITUTED 1-CARBONYLAMINO-3-PIPERIDINAMINOBENZENES AS 5-HT1F AGONISTS | Sep 27, 2010 | Abandoned |
Array
(
[id] => 5993575
[patent_doc_number] => 20110015228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE'
[patent_app_type] => utility
[patent_app_number] => 12/891632
[patent_app_country] => US
[patent_app_date] => 2010-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 11692
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015228.pdf
[firstpage_image] =>[orig_patent_app_number] => 12891632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/891632 | POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE | Sep 26, 2010 | Abandoned |
Array
(
[id] => 8324483
[patent_doc_number] => 20120196896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'Treatment for Oxidative Stress and/or Hypertension'
[patent_app_type] => utility
[patent_app_number] => 13/395764
[patent_app_country] => US
[patent_app_date] => 2010-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18519
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395764
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/395764 | Treatment for oxidative stress and/or hypertension | Sep 16, 2010 | Issued |
Array
(
[id] => 8371176
[patent_doc_number] => 20120220564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'SELECTIVE CALCIUM CHANNEL MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/496648
[patent_app_country] => US
[patent_app_date] => 2010-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18014
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496648
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/496648 | SELECTIVE CALCIUM CHANNEL MODULATORS | Sep 16, 2010 | Abandoned |